The massive infiltration of peripheral immune cells at late tumor stages was accompanied by a diversification of phenotypes of the fluorescent cells as indicated by the detection of CD11c-EYFP+ cells in populations I (10.4%), and II (10%). Here, ITGAX is linked to neoplasm.